Skip to main content
. Author manuscript; available in PMC: 2016 Dec 19.
Published in final edited form as: Pharmacogenet Genomics. 2014;24(5):256–262. doi: 10.1097/FPC.0000000000000045

Table 4.

Univariate analysis of factors influencing leucopenia using time dependent Cox proportional hazards regression models. The total number of events among the whole protocol visits were studied.

* Covariate Category HR (95%CI) p value
EC_MPS dose Per unit increase 0.999 (0.998,1.000) 0.2220

Age Per year increase 1.03 (0.99,1.07) 0.1400

Sex F vs M 1.66 (0.73,3.76) 0.2270

Randomization group with vs. without steroids 0.61 (0.27,1.38) 0.2380

IMPDH2 IVS7+10 T>C (rs11706052) TT vs. TC/CC 6.14 (0.83,45.58) 0.0761

IMPDH1 C>T (rs2278923) CT vs. CC 4.84 (1.12,20.97) 0.0351
TT vs. CC 3.35 (0.65,17.33) 0.1489

IMPDH1 C>T (rs2278924) CT vs. CC 1.42 (0.60,3.34) 0.4200
TT vs. CC 0.98 (0.21,4.56) 0.9770

ABCC2 -24 C>T (rs717620) CT vs. CC 0.83 (0.35,2.02) 0.6890

ABCC2 1249 G>A (rs2273697) GG vs. GA/AA 0.89 (0.39,2.03) 0.7880

ABCC2 3972 C>T (rs3740066) CT vs. CC 0.42 (0.14,1.23) 0.1147
TT vs. CC 2.45 (0.99,6.07) 0.0533

ABCC2 4544 G>A (rs8187710) GG vs. GA/AA 4.82 (0.65,35.81) 0.1240

SLCO1B3 334 T>G (rs4149117) TG/TT vs. GG 1.60 (0.70,3.65) 0.2620

UGT1A8 518 C>G (rs1042597) CG/GG vs. CC 1.64 (0.73,3.67) 0.2270

UGT1A9 -2152 C>T (rs17868320) CT vs. CC 0 (0,Inf) 1.0000

UGT1A9 -275 T>A TT vs. TA/AA 2.38 (0.32,17.67) 0.3970

UGT 2B7 -840 G>A (rs7438135) GA vs. AA 0.57 (0.22,1.46) 0.2430
GG vs. AA 0.69 (0.24,1.99) 0.4910

CYP2C8 G>A
rs11572076
GG vs. GA 0.14 (0.03,0.59) 0.0078

HUS1 G>A
rs1056663
GA vs. AA 0.70 (0.23,2.08) 0.5180
GG vs. AA 1.07 (0.36,3.21) 0.9000

IL12A G>A
rs568408
GG vs. GA/AA 0.55 (0.22,1.41) 0.2140
*

cyclosporine C2 was not evaluated due to a high number of missing values (487/1398), totally at random